(NASDAQ: INGN) Inogen's forecast annual revenue growth rate of 3.24% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Inogen's revenue in 2024 is $315,660,000.On average, 3 Wall Street analysts forecast INGN's revenue for 2024 to be $7,494,732,090, with the lowest INGN revenue forecast at $7,382,460,284, and the highest INGN revenue forecast at $7,581,204,475. On average, 3 Wall Street analysts forecast INGN's revenue for 2025 to be $7,842,371,137, with the lowest INGN revenue forecast at $7,748,924,045, and the highest INGN revenue forecast at $7,933,438,898.
In 2026, INGN is forecast to generate $8,212,427,223 in revenue, with the lowest revenue forecast at $8,212,427,223 and the highest revenue forecast at $8,212,427,223.